This announcement is a separate document:
中國抗體-B：截至二零二一年十二月三十一日止年度全年業績公告及更改所得款項用途
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENT FORTHE YEAR ENDED 31 DECEMBER 2021AND CHANGE IN USE OF PROCEEDS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.